TNFRSF9 and autoimmune disease: Since the CD137-CD137L interaction mainly promotes a type 1 helper T cell response, CD137L downregulation by trogocytosis potentially ameliorates autoimmune diseases that are characterized by a Th1 polarization such as type 1 diabetes [27].